Cargando…
Hypoxia-altitude simulation test to predict altitude-related adverse health effects in COPD patients
BACKGROUND/AIMS: Amongst numerous travellers to high altitude (HA) are many with the highly prevalent COPD, who are at particular risk for altitude-related adverse health effects (ARAHE). We then investigated the hypoxia-altitude simulation test (HAST) to predict ARAHE in COPD patients travelling to...
Autores principales: | Bauer, Meret, Müller, Julian, Schneider, Simon R., Buenzli, Simone, Furian, Michael, Ulrich, Tanja, Carta, Arcangelo F., Bader, Patrick R., Lichtblau, Mona, Taalaibekova, Ajian, Raimberdiev, Madiiar, Champigneulle, Benoit, Sooronbaev, Talant, Bloch, Konrad E., Ulrich, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009702/ https://www.ncbi.nlm.nih.gov/pubmed/36923563 http://dx.doi.org/10.1183/23120541.00488-2022 |
Ejemplares similares
-
Counseling Patients with Chronic Obstructive Pulmonary Disease Traveling to High Altitude
por: Bloch, Konrad E., et al.
Publicado: (2023) -
Asthma rehabilitation at high vs. low altitude: randomized parallel-group trial
por: Saxer, Stéphanie, et al.
Publicado: (2019) -
Effect of acetazolamide on pulmonary vascular haemodynamics in patients with COPD going to altitude: a randomised, placebo-controlled, double-blind trial
por: Lichtblau, Mona, et al.
Publicado: (2023) -
Validation of Noninvasive Assessment of Pulmonary Gas Exchange in Patients with Chronic Obstructive Pulmonary Disease during Initial Exposure to High Altitude
por: Champigneulle, Benoit, et al.
Publicado: (2023) -
Visuomotor performance at high altitude in COPD patients. Randomized placebo-controlled trial of acetazolamide
por: Scheiwiller, P. M., et al.
Publicado: (2022)